28 March 2018

5th International Atacama-Leh Symposium meeting report


The 5th International Atacama-Leh Symposium took place on 4 to 9 March 2018 in one of the driest and certainly most beautiful places in the world – the Atacama Desert in Chile. San Pedro de Atacama is located on a plateau at 2,408 meters altitude offering a spectacular view to the surrounding volcanoes, including Licancabur at the border between Chile and Bolivia.

This year's meeting was the 5th meeting since the first Leh symposium in 2010 in Leh, Ladakh, India. The conference was very well organised and chaired by Drs Max Gassmann, Norbert Weissmann and Emilio Herrera and assisted by Nuria Fabregas Bregolat. The organisers arranged an excellent and balanced scientific programme as well as unique social events, including the visit of ALMA – the currently largest radio telescope observatory in the world at the Chajnantor Plateau in the Atacama Desert.


The conference theme was Coping with hypoxia at high altitude: How lung, blood and brain respond and crosstalk offering a broad insight into different high altitude research fields, eg pulmonary hypertension and chronic as well as acute mountain sickness. 50 researchers that represented 13 different countries from South- and North America, as well as Europe attended the conference. We had the opportunity to listen to 32 exciting talks and to discuss 15 excellent posters. In addition, three posters were chosen for a short oral presentation. The full report summarises the science presented in its various form at the meeting from our personal point of view and our memories.

Of course that way it is almost impossible to give full credit to all the excellent presentations and the organisers apologise if some attendees' work is underrepresented in the report, which is by no means a reflection of scientific quality or importance.

The organisers and all participants kindly thank the kind contribution of our sponsor PVRI.

Comments (0)

Our research platform is the world.

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI